Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy ...Middle East

LUND, Sweden, Aug. 1, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces enhanced performance for its next-generation test for detecting stage 1 and 2 pancreatic ductal adenocarcinomas (PDAC) in high-risk individuals,...

Hence then, the article about immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy was published today ( Thursday 01/08/2024 - 10:57 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy )

Also on site :

• UN renews Sudan ceasefire appeal over ‘unimaginable suffering’ of civilians
• Central African Republic election: Who’s running and what’s at stake?
• Israeli forces continue ceasefire violations with attacks across Gaza